Established in 2001, NTA’s purpose is to build a world-class service capability for clinical trials
NTA is now a highly respected CRO playing a key role in transitioning research and development into clinical practice, and creating improved clinical outcomes for patients.
NTA continues to invest in the neuroscience clinical ecosystem by funding neuroscience research undertaken at The Florey. The Florey is the largest brain research centre in the southern hemisphere, and one of the largest independent medical research institutes in Australia.
NTA is uniquely positioned to provide client’s direct access to therapeutic disease groups, key opinion leaders and clinical trial sites.
Our 20 years’ experience have given our professional team expertise in a wide range of therapeutic and clinical areas — within Australia and globally. The Australian legal and regulatory environment makes us an ideal partner.
Team of experts
Although NTA mainly works in the neuroscience space, we also increasingly support our client’s portfolios in other therapeutic indications including oncology tracers, immunology, ophthalmology, genetic disorders, endocrinology, allergy, COVID-19, devices, diagnostics and sleep disorders.